![]() |
weeble, good luck with your decision hun. Much respect! :hug:
|
I am going to ask Jim's spinal cord doctor to look and see if Jim ever had the HLA test. We don't remember because it's been so long ago, 20 years.
|
Quote:
They like drug virgins, and since I don't intend to take anything else anyway, maybe this would be a good option for me. Could you please let me know what you find out; where the trial center is, lead researcher in BC, trial criteria, etc. if they give you the documentation on it? Thanks! |
Quote:
|
Quote:
|
This really sounds very pomising for all of you/us. Why is it always two to 5 years off.:confused:
I'm too old for trials, but too young to not, still, have hope.:) Bring it on!!!! :cool: Keep us tuned, Kelly..:hug: |
That's right Sally! Sounds like everyone will possibly benefit from this drug.
|
Quote:
|
Multiple Sclerosis drug dirucotide (MBP8298) receives fast track designation from FDA
BioMS Medical Corp. announced that the Food and Drug Administration (FDA) of the United States has granted fast track designation for the Company's lead drug, dirucotide (MBP8298), for the treatment of secondary progressive MS (SPMS). Dirucotide (MBP8298) is currently being evaluated in a U.S. pivotal phase III trial, named MAESTRO-03, at 68 sites with approximately 510 patients. Fast track designation is an FDA status reserved for products that are intended to treat a serious or life-threatening condition and that demonstrate the potential to address unmet medical needs for that condition. Fast track designation can potentially facilitate development and expedite the review process. "Our receipt of fast track designation for dirucotide in the U.S. is a significant milestone for both BioMS Medical and the MS community," said Kevin Giese, President and CEO of BioMS Medical. "Based on previous clinical results, we believe dirucotide is well-positioned to become a first-in-class treatment for secondary progressive MS patients, a large patient population with very limited treatment options." Source: BioMS Medical Corp. (04/09/08) http://www.msrc.co.uk/index.cfm?fuse...ow&pageid=1308 |
The Trials are closed, fully subscribed by patients and Doctors. I believe the Canadian/European trial is finished. I believe Fast Track is what Tysabri got.
|
All times are GMT -5. The time now is 12:49 AM. |
Powered by vBulletin Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise (Lite) -
vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.